{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:36:11Z","timestamp":1765546571301,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.mehy.2020.109754","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T20:30:31Z","timestamp":1587587431000},"page":"109754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["5-Fluorouracil in combination with deoxyribonucleosides and deoxyribose as possible therapeutic options for the Coronavirus, COVID-19 infection"],"prefix":"10.1016","volume":"142","author":[{"given":"Shamim I.","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.109754_b0005","article-title":"Clinical trial analysis of 2019-nCoV therapy registered in China","author":"Zhang","year":"2020","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.mehy.2020.109754_bib136","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.joim.2020.02.005","article-title":"In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus","volume":"18","author":"Zhang","year":"2020","journal-title":"T Integr Med"},{"key":"10.1016\/j.mehy.2020.109754_b0010","doi-asserted-by":"crossref","first-page":"101615","DOI":"10.1016\/j.tmaid.2020.101615","article-title":"Remdesivir as a possible therapeutic option for the COVID-19","author":"Al-Tawfiq","year":"2020","journal-title":"Travl Med Infect Dis"},{"issue":"1","key":"10.1016\/j.mehy.2020.109754_b0015","first-page":"48","article-title":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)","volume":"14","author":"Dong","year":"2020","journal-title":"Drug Discov"},{"key":"10.1016\/j.mehy.2020.109754_b0020","doi-asserted-by":"crossref","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","author":"Gao","year":"2020","journal-title":"BioSci Trends"},{"key":"10.1016\/j.mehy.2020.109754_b0025","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00399-20","article-title":"Compounds with therapeutic potential against novel respiratory 2019 coronavirus","author":"Martinez","year":"2020","journal-title":"Antimicrobes Agents Chemother"},{"key":"10.1016\/j.mehy.2020.109754_b0030","article-title":"The antiviral compound Remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome","author":"Gordon","year":"2020","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.mehy.2020.109754_b0035","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.3346\/jkms.2020.35.e79","article-title":"Case of the index patients who caused tertiary transmission of COVID-19 infection in Korea: the application of Lopinavir\/Ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR","volume":"35","author":"Lim","year":"2020","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.mehy.2020.109754_b0040","doi-asserted-by":"crossref","first-page":"104762","DOI":"10.1016\/j.antiviral.2020.104762","article-title":"Of chloroquine and COVID-19","volume":"177","author":"Touret","year":"2020","journal-title":"Antiviral Res"},{"issue":"12","key":"10.1016\/j.mehy.2020.109754_b0045","doi-asserted-by":"crossref","first-page":"65418","DOI":"10.1128\/JVI.00110-15","article-title":"Mutation in Coronavirus non-structural protein 10 decreases virus replication fidelity","volume":"89","author":"Smith","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2020.109754_b0050","doi-asserted-by":"crossref","unstructured":"Bassi MR, Sempere RN, Meyn P et al. Extinction of Zika Virus and Usutu Virus by lethal mutagenesis reveals different patterns of sensitivity to three mutagenic drugs. Antimicrob Agents Chemother. 2018 August 27;62(9). pii: e00380-18. doi: 10.1128\/AAC.00380-18. Print 2018 Sep.","DOI":"10.1128\/AAC.00380-18"},{"issue":"8","key":"10.1016\/j.mehy.2020.109754_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003565","article-title":"Coronavirus lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics","volume":"9","author":"Smith","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mehy.2020.109754_b0060","doi-asserted-by":"crossref","unstructured":"Sexton NR, Smith, EC, Blanc H et al. Homology-based identification of a mutation in the coronavirus RNA-dependent RNA polymerase that confers resistance to multiple mutagenesis. J Virol, 2016 July 27;90(16):7415-7428. doi: 10.1128\/JVI.00080-16. Print 2016 Aug 15.","DOI":"10.1128\/JVI.00080-16"},{"key":"10.1016\/j.mehy.2020.109754_b0065","doi-asserted-by":"crossref","unstructured":"Carson DA, Kaye J, Seegmiller JE. PNAS December 1, 1977 74(12)5677-5681; doi: 10.1073\/pnas.74.12.5677.","DOI":"10.1073\/pnas.74.12.5677"},{"key":"10.1016\/j.mehy.2020.109754_b0070","unstructured":"Staal GE, Stoop JW, Zegers BJ et al. Erythrocyte metabolism in purine nucleoside phosphorylase deficiency after enzyme replacement therapy by infusion of erythrocytes. Free Access \u2013 25.3.2020. doi: 10.1172\/JCL109639."},{"key":"10.1016\/j.mehy.2020.109754_b0075","unstructured":"Purine nucleoside phosphorylase deficiency Genetic and Rare Diseases information Center25.3.2020."},{"key":"10.1016\/j.mehy.2020.109754_b0080","doi-asserted-by":"crossref","unstructured":"Hirano M, MartiR, Spinazzola A. Thymidine phosphorylase deficiency causes MNGIE: an autosomal recessive mitochondrial disorder. Nucleosides Nucleotides Nucl Acids 2004 Oct;23(8-9):1217\u20131225.","DOI":"10.1081\/NCN-200027485"},{"key":"10.1016\/j.mehy.2020.109754_b0085","doi-asserted-by":"crossref","unstructured":"Yadak, R, Smitt, PS, van Gisbergen et al. Mitochondrial neurogastrointestinal encephalomyopathy caused by thymidine phosphorylase enzyme deficiency: from pathogenesis to merging therapeutic options. Fron Cell Neurosci. 2017, 11:31 Feb 15. doi: 103389\/fncel.2017.00031.","DOI":"10.3389\/fncel.2017.00031"},{"key":"10.1016\/j.mehy.2020.109754_b0090","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF00334234","article-title":"A map of four genes specifying enzymes involved in catabolism of nucleosides and deoxynucleosides in Escherichia coli","volume":"104","author":"Ahmad","year":"1969","journal-title":"Molec Gen Genet"},{"key":"10.1016\/j.mehy.2020.109754_b0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF00286556","article-title":"A regulatory mutant affecting the synthesis of enzymes involved in the catabolism of nucleosides in Escherichia coli","volume":"111","author":"Ahmad","year":"1971","journal-title":"Molec Gen Genet"},{"key":"10.1016\/j.mehy.2020.109754_b0100","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF00286557","article-title":"Fluorouracil and the isolation of mutants lacking uridine phosphorylase in Escherichia coli: location of gene","volume":"111","author":"Pritchard","year":"1971","journal-title":"Mol. Gen. Genet."},{"key":"10.1016\/j.mehy.2020.109754_b0105","doi-asserted-by":"crossref","unstructured":"Agostini ML, Pruijesser AJ, Chappell JD et al. Small molecule anti viral Beta-d-N4-hydroxycytidine inhibits a proofreading-intact coronavirus with a high genetic barrier to resistance. J Virol, 2019 Nov 26;93(24). pil: e01348-19. doi: 10.1128\/JVI.01348-19. Print Dec 15.","DOI":"10.1128\/JVI.01348-19"},{"issue":"6","key":"10.1016\/j.mehy.2020.109754_b0110","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00280-018-3676-7","article-title":"Enhancing 5-fluorouracil efficacy through suppression of PKM2 in colorectal cancer","volume":"82","author":"CaoY","year":"2018","journal-title":"Cancer Chemother Pharmacol."},{"issue":"3","key":"10.1016\/j.mehy.2020.109754_b0115","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41419-019-1487-3","article-title":"NAA40 contributes colorectal cancer growth by controlling PRMT5 expression","volume":"10","author":"Demetriadou","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.mehy.2020.109754_b0120","doi-asserted-by":"crossref","unstructured":"Inoko K, Hiraoka K, Inagaki A et al. Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer. Cancer Gene Ther. 2018 Aug;25(7-8);184-195. doi: 10.1038\/s41417-018-0020-7. Epub 2018 May 8.","DOI":"10.1038\/s41417-018-0020-7"},{"key":"10.1016\/j.mehy.2020.109754_b0125","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.oraloncology.2017.12.017","article-title":"Viable tumour in salvage neck dissertations in head and neck cancer: relation with initial treatment, change of lymph node size and human papillomavirus","author":"Van den Bovenkamp","year":"2018","journal-title":"Oral Oncol"},{"key":"10.1016\/j.mehy.2020.109754_b0130","doi-asserted-by":"crossref","unstructured":"Wang D, Chen Y, Fang H et al. Increase of PRPP enhances chemosensitivity of PRPS1 mutatnt acute lymphoblastic leukaemia cells to 5-fluorouracil. J Cell Mol Med 2018 Dec;22(12):6202-6212. doi: 10.1111\/jcmm.13907. Epub 2018 Sep 25.","DOI":"10.1111\/jcmm.13907"},{"issue":"2","key":"10.1016\/j.mehy.2020.109754_b0135","first-page":"347","article-title":"Suicide gene armed measles vaccine virus for the treatment of AML","volume":"55","author":"Maurer","year":"2019","journal-title":"Int J Oncol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720305788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720305788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:24:19Z","timestamp":1759692259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720305788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":28,"alternative-id":["S0306987720305788"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109754","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-Fluorouracil in combination with deoxyribonucleosides and deoxyribose as possible therapeutic options for the Coronavirus, COVID-19 infection","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109754","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109754"}}